Logo image of KRMD

KORU MEDICAL SYSTEMS INC (KRMD) Stock Fundamental Analysis

NASDAQ:KRMD - Nasdaq - US7599101026 - Common Stock - Currency: USD

3.71  -0.17 (-4.38%)

After market: 3.71 0 (0%)

Fundamental Rating

3

Overall KRMD gets a fundamental rating of 3 out of 10. We evaluated KRMD against 189 industry peers in the Health Care Equipment & Supplies industry. KRMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KRMD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KRMD had negative earnings in the past year.
In the past year KRMD has reported a negative cash flow from operations.
KRMD had negative earnings in 4 of the past 5 years.
KRMD had negative operating cash flow in 4 of the past 5 years.
KRMD Yearly Net Income VS EBIT VS OCF VS FCFKRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

KRMD has a worse Return On Assets (-48.29%) than 67.02% of its industry peers.
KRMD's Return On Equity of -67.53% is in line compared to the rest of the industry. KRMD outperforms 42.02% of its industry peers.
Industry RankSector Rank
ROA -48.29%
ROE -67.53%
ROIC N/A
ROA(3y)-26.59%
ROA(5y)-15.76%
ROE(3y)-35.88%
ROE(5y)-21.2%
ROIC(3y)N/A
ROIC(5y)N/A
KRMD Yearly ROA, ROE, ROICKRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

With a Gross Margin value of 58.60%, KRMD perfoms like the industry average, outperforming 55.32% of the companies in the same industry.
In the last couple of years the Gross Margin of KRMD has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for KRMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.22%
KRMD Yearly Profit, Operating, Gross MarginsKRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KRMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KRMD has more shares outstanding
Compared to 5 years ago, KRMD has more shares outstanding
KRMD has a worse debt/assets ratio than last year.
KRMD Yearly Shares OutstandingKRMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
KRMD Yearly Total Debt VS Total AssetsKRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

KRMD has an Altman-Z score of 11.92. This indicates that KRMD is financially healthy and has little risk of bankruptcy at the moment.
KRMD has a better Altman-Z score (11.92) than 89.89% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that KRMD is not too dependend on debt financing.
KRMD has a Debt to Equity ratio of 0.03. This is in the better half of the industry: KRMD outperforms 62.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 11.92
ROIC/WACCN/A
WACC9.04%
KRMD Yearly LT Debt VS Equity VS FCFKRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 4.55 indicates that KRMD has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.55, KRMD is doing good in the industry, outperforming 75.00% of the companies in the same industry.
KRMD has a Quick Ratio of 3.77. This indicates that KRMD is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.77, KRMD is doing good in the industry, outperforming 74.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 3.77
KRMD Yearly Current Assets VS Current LiabilitesKRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

KRMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.18%, which is quite impressive.
The Revenue has been growing slightly by 2.21% in the past year.
KRMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.45% yearly.
EPS 1Y (TTM)41.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)2.21%
Revenue growth 3Y5.65%
Revenue growth 5Y10.45%
Sales Q2Q%16.84%

3.2 Future

Based on estimates for the next years, KRMD will show a very strong growth in Earnings Per Share. The EPS will grow by 22.22% on average per year.
KRMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.48% yearly.
EPS Next Y17.25%
EPS Next 2Y20.22%
EPS Next 3Y22.22%
EPS Next 5YN/A
Revenue Next Year19.29%
Revenue Next 2Y16.58%
Revenue Next 3Y16.48%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRMD Yearly Revenue VS EstimatesKRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
KRMD Yearly EPS VS EstimatesKRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

KRMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KRMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRMD Price Earnings VS Forward Price EarningsKRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRMD Per share dataKRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

KRMD's earnings are expected to grow with 22.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.22%
EPS Next 3Y22.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KRMD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KORU MEDICAL SYSTEMS INC

NASDAQ:KRMD (2/21/2025, 8:00:02 PM)

After market: 3.71 0 (0%)

3.71

-0.17 (-4.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-12 2025-03-12/amc
Inst Owners51.03%
Inst Owner ChangeN/A
Ins Owners6.35%
Ins Owner Change8.75%
Market Cap170.07M
Analysts81.82
Price Target5.61 (51.21%)
Short Float %0.84%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.82%
Min EPS beat(2)26.47%
Max EPS beat(2)41.18%
EPS beat(4)4
Avg EPS beat(4)20.78%
Min EPS beat(4)1.96%
Max EPS beat(4)41.18%
EPS beat(8)7
Avg EPS beat(8)19.61%
EPS beat(12)9
Avg EPS beat(12)-14.5%
EPS beat(16)9
Avg EPS beat(16)-41.86%
Revenue beat(2)1
Avg Revenue beat(2)-6%
Min Revenue beat(2)-13.45%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-5.1%
Min Revenue beat(4)-13.45%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-0.96%
Revenue beat(12)8
Avg Revenue beat(12)1.25%
Revenue beat(16)10
Avg Revenue beat(16)0.01%
PT rev (1m)12.24%
PT rev (3m)34.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.53%
EPS NY rev (3m)7.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)4.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.96
P/FCF N/A
P/OCF N/A
P/B 8.36
P/tB 8.68
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.62
BVpS0.44
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.29%
ROE -67.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.6%
FCFM N/A
ROA(3y)-26.59%
ROA(5y)-15.76%
ROE(3y)-35.88%
ROE(5y)-21.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.22%
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.59%
Cap/Sales 2.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 3.77
Altman-Z 11.92
F-Score4
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)216.93%
Cap/Depr(5y)205.93%
Cap/Sales(3y)4.84%
Cap/Sales(5y)4.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y17.25%
EPS Next 2Y20.22%
EPS Next 3Y22.22%
EPS Next 5YN/A
Revenue 1Y (TTM)2.21%
Revenue growth 3Y5.65%
Revenue growth 5Y10.45%
Sales Q2Q%16.84%
Revenue Next Year19.29%
Revenue Next 2Y16.58%
Revenue Next 3Y16.48%
Revenue Next 5YN/A
EBIT growth 1Y4.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.26%
EBIT Next 3Y33.79%
EBIT Next 5YN/A
FCF growth 1Y30.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.4%
OCF growth 3YN/A
OCF growth 5YN/A